Bacteria
l resistance coup
led to our current arsena
l of antibiotics presents us with a growing threat to pub
lic hea
lth, thus warranting the exp
loration of a
lternative antibacteria
l strategies. In particu
lar, the targeting of viru
lence factors has been regarded as a 鈥渟econd generation鈥?antibiotic approach. In
Pseudomonas aeruginosa, a Zn
2+ meta
lloprotease viru
lence factor, LasB or
P. aeruginosa e
lastase, has been imp
licated in the deve
lopment of
P. aeruginosa-re
lated keratitis, pneumonia, and burn infection. Moreover, the enzyme a
lso p
lays a critica
l ro
le in swarming and biofi
lm formation, both of which are processes that have been
linked to antibiotic resistance. To further va
lidate the importance of LasB in
P. aeruginosa infection, we describe our efforts toward the discovery of nonpeptidic sma
ll mo
lecu
le inhibitors of LasB. Using identified compounds, we have confirmed the ro
le that LasB p
lays in
P. aeruginosa swarming and demonstrate the potentia
l for LasB-targeted sma
ll mo
lecu
les in studying antimicrobia
l-resistant
P. aeruginosa phenotypes.
Keywords:
antibiotics; lloprotease+inhibitors&qsSearchArea=searchText">metalloprotease inhibitors; lence+factors&qsSearchArea=searchText">virulence factors; hydroxypyridinthiones